392 related articles for article (PubMed ID: 23816419)
1. Risks associated with the transfusion of various blood products in aortic valve replacement.
Bjursten H; Al-Rashidi F; Dardashti A; Brondén B; Algotsson L; Ederoth P
Ann Thorac Surg; 2013 Aug; 96(2):494-9. PubMed ID: 23816419
[TBL] [Abstract][Full Text] [Related]
2. Aortic and mitral valve surgery on the beating heart is lowering cardiopulmonary bypass and aortic cross clamp time.
Gersak B; Sutlic Z
Heart Surg Forum; 2002; 5(2):182-6. PubMed ID: 12125670
[TBL] [Abstract][Full Text] [Related]
3. Aortic valve replacement in octogenarians: risk factors for early and late mortality.
Melby SJ; Zierer A; Kaiser SP; Guthrie TJ; Keune JD; Schuessler RB; Pasque MK; Lawton JS; Moazami N; Moon MR; Damiano RJ
Ann Thorac Surg; 2007 May; 83(5):1651-6; discussion 1656-7. PubMed ID: 17462374
[TBL] [Abstract][Full Text] [Related]
4. The effect on long-term survival of erythrocyte transfusion given for cardiac valve operations.
Engoren M; Habib RH; Hadaway J; Zacharias A; Schwann TA; Riordan CJ; Durham SJ; Shah A
Ann Thorac Surg; 2009 Jul; 88(1):95-100, 100.e1-3. PubMed ID: 19559202
[TBL] [Abstract][Full Text] [Related]
5. Aortic valve replacement in isolated severe aortic stenosis with left ventricular dysfunction: long-term survival and ventricular recovery.
Rabus MB; Kirali K; Kayalar N; Tuncer EY; Toker ME; Yakut C
Anadolu Kardiyol Derg; 2009 Feb; 9(1):41-6. PubMed ID: 19196573
[TBL] [Abstract][Full Text] [Related]
6. Transcatheter aortic valve replacement: does kidney function affect outcome?
Goebel N; Baumbach H; Ahad S; Voehringer M; Hill S; Albert M; Franke UF
Ann Thorac Surg; 2013 Aug; 96(2):507-12. PubMed ID: 23773729
[TBL] [Abstract][Full Text] [Related]
7. Non-red blood cell transfusion as a risk factor for mortality following percutaneous coronary intervention.
Robinson SD; Janssen C; Fretz EB; Chase AJ; Siega AD; Carere RG; Fung A; Simkus G; Hilton JD; Berry B; Klinke WP
Int J Cardiol; 2012 May; 157(2):169-73. PubMed ID: 21215470
[TBL] [Abstract][Full Text] [Related]
8. Is the aortic valve pathology type different for early and late mortality in concomitant aortic valve replacement and coronary artery bypass surgery?
Gunay R; Sensoz Y; Kayacioglu I; Tuygun AK; Balci AY; Kisa U; Demirtas MM; Yekeler I
Interact Cardiovasc Thorac Surg; 2009 Oct; 9(4):630-4. PubMed ID: 19625469
[TBL] [Abstract][Full Text] [Related]
9. Effect of concomitant coronary artery disease on procedural and late outcomes of transcatheter aortic valve implantation.
Dewey TM; Brown DL; Herbert MA; Culica D; Smith CR; Leon MB; Svensson LG; Tuzcu M; Webb JG; Cribier A; Mack MJ
Ann Thorac Surg; 2010 Mar; 89(3):758-67; discussion 767. PubMed ID: 20172123
[TBL] [Abstract][Full Text] [Related]
10. Aortic valve replacement: a safe and durable option in patients with impaired left ventricular systolic function.
Chukwuemeka A; Rao V; Armstrong S; Ivanov J; David T
Eur J Cardiothorac Surg; 2006 Feb; 29(2):133-8. PubMed ID: 16386914
[TBL] [Abstract][Full Text] [Related]
11. Aortic valve replacement and concomitant coronary artery bypass: assessing the impact of multiple grafts.
Kobayashi KJ; Williams JA; Nwakanma L; Gott VL; Baumgartner WA; Conte JV
Ann Thorac Surg; 2007 Mar; 83(3):969-78. PubMed ID: 17307443
[TBL] [Abstract][Full Text] [Related]
12. Results of concomitant aortic valve replacement and coronary artery bypass grafting in the VA population.
Alsoufi B; Karamlou T; Slater M; Shen I; Ungerleider R; Ravichandran P
J Heart Valve Dis; 2006 Jan; 15(1):12-8; discussion 18-9. PubMed ID: 16480007
[TBL] [Abstract][Full Text] [Related]
13. Management of blood transfusion in aortic valve surgery: impact of a blood conservation strategy.
Yaffee DW; Smith DE; Ursomanno PA; Hill FT; Galloway AC; DeAnda A; Grossi EA
Ann Thorac Surg; 2014 Jan; 97(1):95-101. PubMed ID: 24263014
[TBL] [Abstract][Full Text] [Related]
14. Blood transfusion after cardiac surgery: is it the patient or the transfusion that carries the risk?
Dardashti A; Ederoth P; Algotsson L; Brondén B; Lührs C; Bjursten H
Acta Anaesthesiol Scand; 2011 Sep; 55(8):952-61. PubMed ID: 21574966
[TBL] [Abstract][Full Text] [Related]
15. Aortic valve replacement for aortic stenosis in patients with left ventricular dysfunction.
Halkos ME; Chen EP; Sarin EL; Kilgo P; Thourani VH; Lattouf OM; Vega JD; Morris CD; Vassiliades T; Cooper WA; Guyton RA; Puskas JD
Ann Thorac Surg; 2009 Sep; 88(3):746-51. PubMed ID: 19699891
[TBL] [Abstract][Full Text] [Related]
16. Aortic valve replacement in patients with previous coronary artery bypass grafting: 10-year experience.
Vohra HA; Pousios D; Whistance RN; Haw MP; Barlow CW; Ohri SK; Livesey SA; Tsang GM
Eur J Cardiothorac Surg; 2012 Mar; 41(3):e1-6. PubMed ID: 22219478
[TBL] [Abstract][Full Text] [Related]
17. Is patient-prosthesis mismatch a perioperative predictor of long-term mortality after aortic valve replacement?
Bianco JC; Qizilbash B; Carrier M; Couture P; Fortier A; Tardif JC; Lambert J; Denault AY
J Cardiothorac Vasc Anesth; 2013 Aug; 27(4):647-53. PubMed ID: 23849521
[TBL] [Abstract][Full Text] [Related]
18. Red cell transfusion is associated with an increased risk for postoperative atrial fibrillation.
Koch CG; Li L; Van Wagoner DR; Duncan AI; Gillinov AM; Blackstone EH
Ann Thorac Surg; 2006 Nov; 82(5):1747-56. PubMed ID: 17062241
[TBL] [Abstract][Full Text] [Related]
19. Debunking the survival bias myth: characterization of mortality during the initial 24 hours for patients requiring massive transfusion.
Brown JB; Cohen MJ; Minei JP; Maier RV; West MA; Billiar TR; Peitzman AB; Moore EE; Cushieri J; Sperry JL;
J Trauma Acute Care Surg; 2012 Aug; 73(2):358-64; discussion 364. PubMed ID: 22846940
[TBL] [Abstract][Full Text] [Related]
20. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
